6. CLINICAL STUDIES
Pe
Observed experimental
proportion
0.95
Ps
Null hypothesis success rate
0.76
ES
Estimated standard error of Pe
0.04
z´
Test statistic
(1)
4.75
p
Associated p-value
< 0,0001
(1) Statistical test: z´ = (Pe-Ps)/SE where SE = sqrt(Pe(1-Pe)/N)
6.1.2 .
Rate response
European patients only:
GROUP
Number of
patients
included
Mean slope
%SRR on
%MR
STD of
slopes
%SRR on
%MR
SE of mean
slope %SRR
on %MR
Lower 95%
CI
Upper 95%
CI
Europe
20
0.77
0.17
0.04
0.69
0.84
Small
Centers
9
0.79
0.18
0.06
0.67
0.91
Large
Centers
11
0.75
0.15
0.05
0.66
0.84
Males
17
0.77
0.16
0.04
0.70
0.85
Females
3
0.73
0.22
0.13
0.47
0.98
SRR: Sensor Rate Reserve
MR: Metabolic Reserve
STD: Standard Deviation
SE: Standard Error
CI: Confidence Interval
6.1.3 .
Adverse events
Event US (N=22)
Number of events*
Number of patients
Percent of patients
Intent to treat but did
not
0
0
0.0
Non-device related
death
0
0
0.0
Explant
0
0
0.0
Complication
0
0
0.0
Observation
0
0
0.0
Serious non-related
other than death
1
1
4.5
SORIN – INTENSIA DR 154 – U152A
17
Summary of Contents for Intensia DR 154
Page 1: ...Implant manual Implantable cardioverter defibrillator DR model 154...
Page 2: ...blank...
Page 3: ......
Page 4: ...blank...